FDA clearances, acquisitions & more: 5 device company notes

Here are five updates from spine and orthopedic device companies in the last two weeks:

Advertisement

1. OrthoPediatrics’ subsidiary, Telos Partners, hired Scott Day as senior vice president and general manager.

2. RTI Surgical is splitting its company into independent entities focused on surgical implants and biologics.

3. Abbott’s Proclaim XR spinal cord stimulation system was approved by the FDA for expanded MRI compatibility.

4. NuVasive’s Attrax Putty has been cleared by the FDA for use in interbody fusions of the thoracolumbar spine.

5. Surgalign Holdings acquired equity interest in Interneural Networks, whose artificial intelligence technology identifies possible pathological states.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.